Research Article
Prevalence of and Risk Factors for Lipoatrophy in Patients with HIV Infection in Nigeria
Table 5
Logistic regression of factors predicting the development of lipoatrophy in the patients with HIV infection.
| Variable | Odds ratio | 95% CI | value |
| Host factor | | | | Age | 1.03 | 0.99–1.07 | 0.15 | Gender (male/female) | 4.34 | 2.29–8.23 | <0.001* | Treatment factor | | | | HAART use (yes/no) | 2.31 | 1.12–4.73 | 0.03* | Disease factor | | | | CD4 count (mm3) | 1.00 | 1.00-1.00 | 0.09 | Viral load (copies/mL) <200/>200 | 1.76 | 1.03–3.00 | 0.46 | Known duration of HIV infection | 1.03 | 0.53–2.00 | 0.94 |
|
|
CI: confidence interval; *statistically significant.
|